Sartorius Stedim Biotech reports 97,330,405 issued shares, 164,752,145 net voting rights as of Sept. 30, 2026
Bitget2026/10/01 14:09- Sartorius Stedim Biotech reported 97,330,405 shares outstanding as of Sept. 30, 2026.
- Theoretical voting rights totaled 164,770,938, including treasury shares.
- Net voting rights stood at 164,752,145.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
ICE brings futures trading to London’s $190 billion-a-day physical gold market
Precia reports 5,733,040 issued shares, 8,350,574 exercisable voting rights as of Aug. 31, 2026
Precia disclosed 5,733,040 issued shares as of Aug. 31, 2026. Theoretical voting rights totaled 8,677,204. Exercisable voting rights stood at 8,350,574, reflecting 326,630 treasury shares without voting rights. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Precia SA published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.
Asia FX: Tech-linked FX could outperform against US Dollar - MUFG
Sumitomo Metal expects global nickel market to stay in surplus in 2027
Crypto prices
More
